Global Statistics

All countries
529,759,083
Confirmed
Updated on May 26, 2022 12:36 am
All countries
486,156,238
Recovered
Updated on May 26, 2022 12:36 am
All countries
6,306,291
Deaths
Updated on May 26, 2022 12:36 am
Thursday, May 26, 2022

Global Statistics

All countries
529,759,083
Confirmed
Updated on May 26, 2022 12:36 am
All countries
486,156,238
Recovered
Updated on May 26, 2022 12:36 am
All countries
6,306,291
Deaths
Updated on May 26, 2022 12:36 am
Molderizer and Safe Shield

S.F. health officials return thousands of life-saving COVID drugs, plead with public to use them

Vaccines don’t always protect infected from ‘long Covid,’ new research shows

FDA: J&J COVID-19 vaccine use limited due to blood clot risk FDA officials said in a statement that they...

Live news: South Korea raises benchmark rate to 1.75% as inflation climbs – Financial Times

Live news: South Korea raises benchmark rate to 1.75% as inflation climbs  Financial Times Source link

Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron

To the Editor: For persons who received a single dose of the Ad26.COV2.S vaccine (Johnson & Johnson–Janssen) against coronavirus disease 2019 (Covid-19),...


San Francisco has returned thousands of doses of life-saving COVID-19 drugs to the state because the people who could have used them didn’t know the treatment was available, public health officials said Wednesday.

Now city officials are sounding an urgent alert to let people know about the antiviral drugs, which must be taken within five days after the onset of COVID symptoms.

Although physicians typically write prescriptions, many patients never let their doctors know they’ve tested positive for COVID, or tell them when it’s already too late to benefit from the pills.

Health officials said that anyone who tests positive for COVID and is at high risk for a serious case should immediately contact a health care provider and ask for one of the drugs, called Paxlovid and Molnupiravir, which stop the virus from spreading in the body. (Molnupiravir cannot be taken during pregnancy or breastfeeding.)

Those eligible include people who are unvaccinated or haven’t had a booster shot, as well as pregnant women, people at least 65 years old, and anyone with a medical condition that puts them at high risk for serious illness.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

Vaccines don’t always protect infected from ‘long Covid,’ new research shows

FDA: J&J COVID-19 vaccine use limited due to blood clot risk FDA officials said in a statement that they...

Live news: South Korea raises benchmark rate to 1.75% as inflation climbs – Financial Times

Live news: South Korea raises benchmark rate to 1.75% as inflation climbs  Financial Times Source link

Related Articles

Vaccines don’t always protect infected from ‘long Covid,’ new research shows

FDA: J&J COVID-19 vaccine use limited due to blood clot risk FDA officials said in a statement that they...

Live news: South Korea raises benchmark rate to 1.75% as inflation climbs – Financial Times

Live news: South Korea raises benchmark rate to 1.75% as inflation climbs  Financial Times Source link